Insider Transactions Reported by 10 Insiders of Eton Pharmaceuticals, Inc.

Symbol
ETON on Nasdaq
Location
Deer Park, IL

Insiders trading volume in the past year

Eton Pharmaceuticals, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Opaleye Management Inc. 10%+ Owner $45,177,234 +$125,484 +0.28% 10 Jun 2025
SEAN BRYNJELSEN President & CEO, Director, 10%+ Owner $45,040,496 -$3,592,611 -7.4% 12 Jan 2026
David Krempa Chief Business Officer $10,050,844 -$504,318 -4.8% 12 Jan 2026
James R. Gruber Chief Financial Officer $3,508,134 -$673,714 -16% 12 Jan 2026
NORBERT G. RIEDEL Director $2,807,103 03 Feb 2026
William Wilson Troutman CFO and Secretary $48,453 07 Feb 2022
Ipek Erdogan-Trinkaus Chief Commercial Officer $40,610 12 Jan 2026
CHARLES J. CASAMENTO Director 12 Jan 2026
PAUL MAIER V. Director 12 Jan 2026
Jennifer McKie Adams Director 12 Jan 2026

Recent Insider Transactions by Companies or Individuals for Eton Pharmaceuticals, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.